+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

A compound heterozygote harboring novel and recurrent DTDST mutations with intermediate phenotype between atelosteogenesis type II and diastrophic dysplasia



A compound heterozygote harboring novel and recurrent DTDST mutations with intermediate phenotype between atelosteogenesis type II and diastrophic dysplasia



American Journal of Medical Genetics. Part A 140(11): 1143-1147



Diastrophic dysplasia sulfate transporter (DTDST) is a sulfate transporter required for the synthesis of sulfated proteoglycans in the cartilage. Over 30 mutations have been described in the DTDST gene, which result in a continuous clinical spectrum of recessively inherited chondrodysplasias, including, in order of increasing severity, a recessive form of multiple epiphyseal dysplasia (rMED), diastrophic dysplasia (DTD), atelosteogenesis type II (AO-II) and achondrogenesis 1B (ACG-1B). Correlation between disease severity and residual sulfate transport activity has been reported. Here we report a patient with DTDST mutations, whose manifestations fell in a range between AO-II and DTD. The patient was a compound heterozygote for the recurrent c.835C>T (p.R279W) and novel c.1987G>A (p.G663R) mutations. Immunocytochemical analysis in HEK293 cells showed that the p.G663R mutation was localized within the cytoplasm, and not to the cell membrane, suggesting p.G663R is a loss-of-function mutation. Our case supports the previously described correlation between the severity of the phenotype and the putative level of residual transport function.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 011681342

Download citation: RISBibTeXText

PMID: 16642506

DOI: 10.1002/ajmg.a.31225


Related references

A compound heterozygote of novel and recurrent DTDST mutations results in a novel intermediate phenotype of Desbuquois dysplasia, diastrophic dysplasia, and recessive form of multiple epiphyseal dysplasia. Journal of Human Genetics 53(8): 764-768, 2008

Genotype-phenotype correlation in DTDST dysplasias: Atelosteogenesis type II and diastrophic dysplasia variant in one family. American Journal of Medical Genetics. Part a 152a(12): 3043-3050, 2010

A phenotype intermediate between Desbuquois dysplasia and diastrophic dysplasia secondary to mutations in DTDST. American Journal of Medical Genetics. Part a 146a(22): 2920-2924, 2008

Atelosteogenesis type II is caused by mutations in the diastrophic dysplasia sulfate-transporter gene (DTDST): evidence for a phenotypic series involving three chondrodysplasias. American Journal of Human Genetics 58(2): 255-262, 1996

Diastrophic dysplasia and atelosteogenesis type II as expression of compound heterozygosis: first report of a Mexican patient and genotype-phenotype correlation. American Journal of Medical Genetics. Part a 129a(2): 190-192, 2004

A compound heterozygote SLC26A2 mutation resulting in robin sequence, mild limbs shortness, accelerated carpal ossification, and multiple epiphysial dysplasia in two Brazilian sisters. A new intermediate phenotype between diastrophic dysplasia and recessive multiple epiphyseal dysplasia. American Journal of Medical Genetics. Part a 161a(8): 2088-2094, 2013

Atelosteogenesis type II is caused by mutations in the diastrophic dysplasia sulfate transporter gene. American Journal of Human Genetics 57(4 Suppl. ): A48, 1995

Mutations in the diastrophic dysplasia sulfate transporter (DTDST) gene: correlation between sulfate transport activity and chondrodysplasia phenotype. Human Molecular Genetics 10(14): 1485-1490, 2001

Defective sulfation of proteoglycans in achondrogenesis type IB is caused by mutations in the DTDST gene The disorder is allelic to diastrophic dysplasia. American Journal of Human Genetics 57(4 Suppl. ): A48, 1995

New intermediate phenotype between MED and DD caused by compound heterozygous mutations in the DTDST gene. American Journal of Medical Genetics. Part a 152a(12): 3036-3042, 2010

Mutations in the diastrophic dysplasia sulfate transporter (DTDST) gene (SLC26A2): 22 novel mutations, mutation review, associated skeletal phenotypes, and diagnostic relevance. Human Mutation 17(3): 159-171, 2001

Functional expression and cellular distribution of diastrophic dysplasia sulfate transporter (DTDST) gene mutations in HEK cells. Human Molecular Genetics 13(19): 2165-2171, 2004

Phenotypic and genotypic overlap between atelosteogenesis type 2 and diastrophic dysplasia. Human Genetics 98(6): 657-661, 1996

Diastrophic dysplasia sulfate transporter (DTDST) gene is not involved in pseudodiastrophic dysplasia. American Journal of Medical Genetics 73(4): 493-494, 1997